Systematically attenuating DNA targeting enables CRISPR-driven editing in bacteria.
Daphne ColliasElena VialettoJiaqi YuKhoa CoÉva D H AlmásiAnn-Sophie RüttigerTatjana AchmedovTill StrowigChase L BeiselPublished in: Nature communications (2023)
Bacterial genome editing commonly relies on chromosomal cleavage with Cas nucleases to counter-select against unedited cells. However, editing normally requires efficient recombination and high transformation efficiencies, which are unavailable in most strains. Here, we show that systematically attenuating DNA targeting activity enables RecA-mediated repair in different bacteria, allowing chromosomal cleavage to drive genome editing. Attenuation can be achieved by altering the format or expression strength of guide (g)RNAs; using nucleases with reduced cleavage activity; or engineering attenuated gRNAs (atgRNAs) with disruptive hairpins, perturbed nuclease-binding scaffolds, non-canonical PAMs, or guide mismatches. These modifications greatly increase cell counts and even improve the efficiency of different types of edits for Cas9 and Cas12a in Escherichia coli and Klebsiella oxytoca. We further apply atgRNAs to restore ampicillin sensitivity in Klebsiella pneumoniae, establishing a resistance marker for genetic studies. Attenuating DNA targeting thus offers a counterintuitive means to achieve CRISPR-driven editing across bacteria.
Keyphrases
- genome editing
- crispr cas
- escherichia coli
- klebsiella pneumoniae
- dna binding
- circulating tumor
- cell free
- single molecule
- cancer therapy
- multidrug resistant
- copy number
- poor prognosis
- nucleic acid
- transcription factor
- single cell
- cell cycle arrest
- cell therapy
- drug delivery
- genome wide
- cell proliferation
- signaling pathway
- biofilm formation
- peripheral blood
- dna repair
- staphylococcus aureus
- binding protein
- case control
- gene expression
- endoplasmic reticulum stress